Accelerate the record!Another new raw material is approved!

Recently, the new raw materials of the "oligoplase-215" of the "oligoplase-215" of Guoscoh Toning were filing through the cosmetics and raw materials of the State Drug Administration.

In August last year, Shenzhen Weiji Pharmaceutical Research and Development Co., Ltd. successfully filed a new raw material "β-osamidal hydroxyl aminaminamine aminotoxine". In April this year, the new raw material "β-nicotinamide monoma" was passed. This time is the 3rd new raw materials passed by Shenzhen Weiji Pharmaceutical Research and Development Co., Ltd., which not only accelerates the speed of declaration, but also brings the first new peptide raw material for domestic filing.

Emerging ingredients, unlimited development potential in the future

The technical requirements of new raw materials show that oligoplase-215 comes from chemical raw materials and can be used for all kinds of skin cosmetics as a skin protective agent. The maximum allowable concentration of the allowable concentration ≤0.3%during use is used.

It is reported that the oligoplase-215 pilot compound activated polypeptide was extracted in the skin of the outer amphibians of the family.

Experiments show that the oligoplase-215 has significant effects in firming and promoting collagen. In terms of promoting skin repair and firming, the birth of the oligoplase-215 is expected to be an emerging component that can replace EGF and can be applied to the epidermis.

As a classification of oligth peptide as a polypeptide, its molecular weight can have higher skin permeability than polypeptides, and it is more likely to be absorbed by human skin. At the same time, due to the small amount of molecular weight, the biological activity has leap in a qualitative leap.

Experts analyzed that peptide skin care products have long been a "anti -aging trump card" for many brands. Due to the unique biological personality and outstanding functional performance, it has huge application space in the field of daily beauty, shampoo, hair care, food and health products, biomedical, and even textiles.

The market is hot, product power upgrade is the key

According to the Guanyan.com industry report, as an emerging market, the market size of biological activated peptides in my country in 2018 was 75.66 billion yuan, an increase of 12.4%year -on -year. It is expected that the market size will exceed 165 billion in 2024.

At the same time, the activated peptide market in the cosmetics industry has also grown year by year. International brands such as Estee Lauder, Lancome, L'Oreal, Chanel, Dior, SK-Ⅱ are all layouts in polypeptide cosmetics categories. Domestic brands such as Baique Ling, Runbaiyan, Maru Mi, and Dr. Takhir are also actively developing peptide skin care products.

In addition, many upstream and upstream companies in the cosmetics industry chain also focus on the research and product development of aging mechanisms and innovative biological activated peptides, and provide health solutions based on biological activated peptides.

The popularity of the peptide cosmetics market is also inseparable from the rise of new concepts such as "ingredient party" and "efficient skin care". The improvement of consumer demand will inevitably attract the brand's attention, thus driving upstream peptide raw materials production enterprises. Therefore, core raw material research and development technology can become a strong market competitor.

Speed ​​speeding up, industry standards need to be established urgently

Since the release of the new regulations, there are currently 18 new cosmetics raw materials in my country have been filed, which has exceeded the sum of new raw materials for more than ten years. Speed ​​up the raw material filing solves the problem of domestic raw material card necks on the one hand, and opens a new direction for many companies. On the other hand, the construction of its standard system is urgently needed to establish and regulate the use and change of new raw materials.

Recently, the China SME Enterprise Association is exported, and the Genang Port (Hong Kong) Biotechnology Co., Ltd. proposed that the "β-nicotinamide single nucleotide" group standards jointly drafted by Yuyao Lafuz Ben Health Technology Co., Ltd. Draft for comments. In January of this year, the NMN passed the National Drug Administration for the record, and we ushered in the first group standard in less than half a year. Not only does the industry gap, it will also accelerate the market growth of the relevant industries.

In March 2021, the State Drug Administration formulated and issued the "Regulations on the Management of New Raw Materials Registration and Recording Data". From the aspects of administration, encourage innovation, adherence to science and simplifying administration, etc., we have refined the registered registered records of new cosmetics, encouraging and supporting the use of modern science and technology, researching and developing new cosmetics raw materials, and promoting the high -quality development of the industry.

The favorable policy trend has made all parties in the industry actively invest in teams for cosmetics and raw materials innovation and research and development. The active attack of local raw materials will drive more enterprises to upgrade their research and development technology. Only by breaking through the continuous advancement of innovation and standard construction can we lay the cornerstone for the "mature market".

- END -